Interventional device developer BioSphere Medical of Rockland, MA, highlighted results from a study that found that uterine artery embolization (UAE) compares well to laparoscopy as a treatment for uterine fibroids.
The study, published in the Journal of Vascular and Interventional Radiology, was conducted by researchers in Norway. Sixty-six women with uterine fibroids were randomized to receive either UAE or laparoscopy; 58 received treatment. Contrast-enhanced MRI was performed before and six months after treatment.
Fourteen women had symptom recurrence after laparoscopy (48%) and five women had symptom recurrence (17%) after UAE. Two women received hysterectomy after UAE (7%), while eight received it after laparoscopy (28%). Complete fibroid infarction was seen in all 26 patients in the UAE group and in only five patients in the laparoscopy group.
The study results further support the level A recommendation of UAE by the American College of Obstetricians and Gynecologists (ACOG) announced last August, BioSphere said.
Related Reading
BioSphere grows Q1 revenues, April 25, 2008
BioSphere names Weinstein to new post, January 22, 2008
BioSphere nets CE Mark OK, December 18, 2007
BioSphere gets FDA nod for QuadraSphere, November 9, 2006
BioSphere launches HepaSphere in Europe, September 23, 2005
Copyright © 2009 AuntMinnie.com
